Psoriasis.
Naldi
Luigi
L
Chatenoud
Liliane
L
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy* / Q000209:etiology*; D012307:Risk Factors
D000319:Adrenergic beta-Antagonists